Evidence map›Paper›PMID 34051629›Full record

ArticleBiomaterials2021

Biomimetic tubular scaffold with heparin conjugation for rapid degradation in in situ regeneration of a small diameter neoartery.

Renato S Navarro, Longtan Jiang, Yang Ouyang, Jiawen Luo, Zhiyong Liu, Ying Yang, Ping Qiu, Kenichi Kuroda, Y Eugene Chen, Peter X Ma and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Functionalization ofBioactive materials · 2023
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Renato S NavarroMacromolecular Science and Engineering Center, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Biologic and Materials Sciences & Prosthodontics, The University of Michigan, Ann Arbor, MI, 48109, USA.
Longtan JiangDepartment of Cardiac Surgery, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Cardiovascular Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China.
Yang OuyangDepartment of Cardiac Surgery, The University of Michigan, Ann Arbor, MI, 48109, USA.
Jiawen LuoDepartment of Cardiac Surgery, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Cardiovascular Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China.
Zhiyong LiuDepartment of Cardiac Surgery, The University of Michigan, Ann Arbor, MI, 48109, USA.
Ying YangDepartment of Cardiac Surgery, The University of Michigan, Ann Arbor, MI, 48109, USA.
Ping QiuDepartment of Cardiac Surgery, The University of Michigan, Ann Arbor, MI, 48109, USA.
Kenichi KurodaMacromolecular Science and Engineering Center, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Biologic and Materials Sciences & Prosthodontics, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Chemistry, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Biomedical Engineering, The University of Michigan, Ann Arbor, MI, 48109, USA.
Y Eugene ChenDepartment of Cardiac Surgery, The University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: echenum@umich.edu.
Peter X MaMacromolecular Science and Engineering Center, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Biologic and Materials Sciences & Prosthodontics, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Biomedical Engineering, The University of Michigan, Ann Arbor, MI, 48109, USA; Department of Material Science and Engineering, The University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: mapx@umich.edu.
Bo YangDepartment of Cardiac Surgery, The University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: boya@umich.edu.
University of Michigan · USCentral South University · CN

Funding

Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
Therapeutic Insights into Loeys-Dietz Syndrome using Humanized ModelsR01HL151776 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bo Yang · 2020 to 2026
$4.2M
Define the mechanisms of aortopathy in bicuspid aortic valve patientsR01HL141891 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YANG, BO · 2018 to 2022
$3.5M
Two-stage miRNA delivering scaffolds for patient-originated cells to regenerate blood vesselsR01HL136231 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2017 to 2020
$3.0M
Regenerating Blood Vessels Using iPS CellsR01HL114038 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MA, PETER X · 2013 to 2016
$2.1M
Effect of mutations in the TGF-beta pathway genes on smooth muscle cell differentiation using patient derived iPSCs.K08HL130614 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YANG, BO · 2016 to 2020
$848k
NHLBI NIH HHS K08 HL130614NHLBI NIH HHS R01 HL114038NHLBI NIH HHS R01 HL136231NHLBI NIH HHS R01 HL141891NHLBI NIH HHS R01 HL151776NIDCR NIH HHS T32 DE007057
6 · The paper itself

Abstract

To address the clinical need for readily available small diameter vascular grafts, biomimetic tubular scaffolds were developed for rapid in situ blood vessel regeneration. The tubular scaffolds were designed to have an inner layer that is porous, interconnected, and with a nanofibrous architecture, which provided an excellent microenvironment for host cell invasion and proliferation. Through the synthesis of poly(spirolactic-co-lactic acid) (PSLA), a highly functional polymer with a norbornene substituting a methyl group in poly(l-lactic acid) (PLLA), we were able to covalently attach biomolecules onto the polymer backbone via thiol-ene click chemistry to impart desirable functionalities to the tubular scaffolds. Specifically, heparin was conjugated on the scaffolds in order to prevent thrombosis when implanted in situ. By controlling the amount of covalently attached heparin we were able to modulate the physical properties of the tubular scaffold, resulting in tunable wettability and degradation rate while retaining the porous and nanofibrous morphology. The scaffolds were successfully tested as rat abdominal aortic replacements. Patency and viability were confirmed through dynamic ultrasound and histological analysis of the regenerated tissue. The harvested tissue showed excellent vascular cellular infiltration, proliferation, and migration with laminar cellular arrangement. Furthermore, we achieved both complete reendothelialization of the vessel lumen and native-like media extracellular matrix. No signs of aneurysm or hyperplasia were observed after 3 months of vessel replacement. Taken together, we have developed an effective vascular graft able to generate small diameter blood vessels that can function in a rat model.

Indexed as

HeparinNanofibersAnimalsBiomimeticsBlood Vessel ProsthesisPolyestersRatsRegenerationTissue EngineeringTissue ScaffoldsHeparinPolyestersHeparin conjugationSmall diameter vascular graftTubular scaffoldVascular smooth muscle cellsVascular tissue engineering

Identifiers

PMID34051629
PMCPMC8390125
OpenAlexW3161799304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.